In the latest Ebola outbreak, a total of 61 cases were recorded and 28 lives were claimed in the Congo region. But now the World Health Organization has reported that the spread of this Ebola outbreak has "largely been contained" after the success of Merck's late-stage vaccination campaign for more than a month.
Scientists from the Melbourne Walter and Eliza Hall Institute and the Howard Hughes Medical Institute (US) have discovered a new vaccine for malaria, revealing an 'atomic-scale' blueprint of how the parasite seize human cells using a new technology called CRYO-EM (cryo-electron microscopy).
A team of scientists from different universities across Europe has developed an innovative method of delivering vaccines directly to the white blood cells in order to boost the immune system against life-threatening diseases. They have devised a tough microcapsule using synthetic spider silk that can deliver vaccines directly to T-cells.
A research team from MIT’s Koch Institute for Integrative Cancer Research in Cambridge, US discovered a novel one-shot nano polio vaccine to eradicate polio. The inactivated polio vaccine was encapsulated in a biodegradable polymer named as PLGA.
As the Democratic Republic of Congo deals with a rising death toll owing to the latest outbreak of Ebola, health officials are moving fast to counter the fatal effects of the deadly virus. Plans are afoot to implement the experimental vaccine developed by Merck & Co to confront the overwhelming challenges posed by the virus.
Developing specialty vaccines for emerging and overlooked infectious diseases is a challenging and rewarding enterprise with specific opportunities and problems. Large companies have not historically prioritized this area and instead have focused on the development and commercialization of routine vaccines and vaccines for diseases with more significant global markets.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.